logo
If you want to protect your brain, this diet beats the Mediterranean diet, new study suggests

If you want to protect your brain, this diet beats the Mediterranean diet, new study suggests

Yahoo5 days ago

New evidence finds that the MIND diet lives up to its name, even when it is started later in life.
Middle-aged and older participants in a large, long-term study were less likely to develop Alzheimer's disease or other types of dementia if they followed a diet filled with green, leafy vegetables, olive oil, whole grains and lots of berries, according to a report presented Monday at the annual meeting of the American Society for Nutrition.
Researchers from University of Hawaii at Mānoa and the University of Southern California discovered that adhering to the MIND diet, which combines the Mediterranean diet with the blood-pressure-lowering DASH diet, results in a stronger and more consistent reduction in dementia risk than what is seen with other healthy diets.
The new findings suggest it's never too late to switch to a healthy diet, said the study's lead author, Song-Yi Park, an associate professor at the University of Hawaii at Mānoa. 'It shows that sticking to a healthy diet, as well as improving the health of the person's diet over time, is very important for older adults who want to prevent dementia.'
While all the Mediterranean-related diets appear to be good for the brain, the MIND dietary pattern was specifically designed for brain health.
'One important difference is that MIND includes berries, which have been linked to brain health,' Park said.
The MIND diet, or Mediterranean-DASH Intervention for Neurodegenerative Delay, scores individual foods based on how protective they are and how much is eaten. Berries — especially strawberries and blueberries — for example, get a score of 1 if two or more servings are consumed per week. The score drops to 0.5 if just one serving per week is consumed and a score of 0 if none are.
A person's individual diet gets an overall rating by adding up the scores for individual foods. The higher the overall score, the better it's for the person's brain.
Park and her colleagues turned to data from nearly 93,000 U.S. adults who had provided information about what they ate as part of a research project known as The Multiethnic Cohort to get a closer look at how diet influenced the risk of developing dementia.
The Multiethnic Cohort was started in the early 1990s through a joint effort of the University of Hawaii Cancer Center and the USC Norris Comprehensive Cancer Center. The men and women enrolled in the study came from five ethnic/racial populations: Japanese Americans, Native Hawaiians, Black Americans, Latinos and whites.
At the outset, the 215,000 participants were ages 45 to 75. When data for the new study was analyzed, more than 21,000 participants had developed Alzheimer's or a related dementia.
At the beginning of the study, people who scored higher for adherence to MIND had a 9% lower risk of developing dementia.
The amount of reduction varied among the racial groups in the new analysis. Greater risk reduction, 13%, was seen in participants who identified as Black, Latino or white.
Participants who improved their adherence to MIND over the 10-year period had a 25% lower risk of dementia compared with those whose adherence declined, and that trend was seen across all age and racial groups.
Some suggestions for reaching the optimal score for the MIND diet, according to a 2015 study:
Leafy green vegetables, such as kale, spinach, broccoli, bok choy and mustard: six or more servings per week
Other vegetables: one serving per day
Nuts, such as almonds, walnuts or pistachios: five or more servings per week
Cheese: less than one per week
Whole grains: three or more per day
Fish (not fried): one or more servings per week
Red meat: less than one serving per week
Fast fried foods: less than one per week
Pastries and sweets: less than five servings per week
Park cautioned that like all observational studies, the new research reports an association and doesn't prove that the diet prevents dementia.
It is a high-quality study, Dr. Walter Willett, a professor of epidemiology and nutrition at the Harvard T.H. Chan School of Public Health and a professor of medicine at the Harvard Medical School, said in an email.
'It adds to the evidence that a Mediterranean-type diet has important benefits for reducing the risk of dementia,' said Willett, who wasn't involved in the research. 'The differences between groups defined by race/ethnicity may well be due to random variation, so at this time it's reasonable to assume that this healthy dietary pattern has benefits for all groups."
When it comes to leafy green vegetables, it's probably best to consume a variety rather than a single type, Willett said.
'In particular, spinach is good in many ways, but has high oxalate content and high intake of spinach can cause kidney stones,' he said.
In general, the MIND diet is in line with the principles of the two diets it's built from, said Dr. Yian Gu, an associate professor of neurological sciences at the Columbia University Irving Medical Center. 'Each of those diets has unique characteristics,' she said.
The Mediterranean diet emphasizes multiple daily servings of fruits and vegetables, along with whole grains, legumes, olive oil, seafood, and nuts and seeds, such as chia, flax, pumpkin and sesame.
DASH, or Dietary Approaches to Stop Hypertension, is meant to prevent hypertension, so it emphasizes low salt, which isn't a major component in the Mediterranean diet.
The MIND diet is easy to follow, Gu said, encouraging people to pick the green, leafy vegetables they prefer. What's important is to increase the diversity of vegetables.
Another benefit of Mediterranean-type diets: They are helpful with other types of chronic disease, including heart disease and cancer, she said.
This article was originally published on NBCNews.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UCSD students protest Trump cuts to science research funding
UCSD students protest Trump cuts to science research funding

Yahoo

time2 hours ago

  • Yahoo

UCSD students protest Trump cuts to science research funding

SAN DIEGO (FOX 5/KUSI) — For the second time this year, students and faculty at the University of California, San Diego (UCSD) staged a protest outside Geisel Library, demanding the federal government reverse deep education funding cuts imposed by the Trump administration — cuts they say are threatening research, jobs and the future of scientific innovation. Dozens of protesters gathered on campus, holding signs and sharing personal stories about how the loss of federal research grants is impacting their work and well-being. Dozens possibly detained by federal officials amid immigration raids in Los Angeles 'This year has been filled with many moments of insecurity,' said Eleanor Ketterer-Sykes, a first-year Ph.D. student in the neuroscience program. 'UCSD is one of the best science schools in the country because of its renowned research labs, you have access to labs at the Salk Institute, Sanford and Scripps as well as the VA Hospital — but that future is in jeopardy.' The Trump administration has canceled hundreds of research grants in recent months, citing concerns over 'ideologically driven science.' The cuts have targeted studies ranging from HIV prevention to violence prevention in children. UCSD Chancellor Pradeep Khosla warned in an April letter that the university stands to lose between $75 million and $500 million annually as a result. 'As of May 30, there have been more than 150 federal grants terminated, resulting in a loss of $30 million,' said Lisa Eyler, a UCSD psychiatry professor. 'These cuts are already leading to layoffs among instructors, staff scientists, and support personnel like librarians.' 'No Kings Day' protests planned across California on June 14 The ripple effects could be felt beyond UCSD. Stanley Maloy, emeritus professor of microbiology at San Diego State University, said the cuts threaten the pipeline of future scientists and engineers. 'Reduced positions mean talented students are left behind,' Maloy said. 'As this innovation workforce dries up, our economy is going to suffer.' Eyler echoed those concerns, warning of a generational loss in scientific progress. 'There will be a gaping hole in the pipeline of future scientists, engineers and healthcare providers, which could result in the potential loss of an entire generation of great scientific thinkers,' she said. Thousands in San Diego protest cuts to federal education funds For Ketterer-Sykes, the issue is personal. She entered the neuroscience program hoping to make life-saving breakthroughs. 'So many people rely on scientific innovation — whether it be to find cures for diseases like tuberculosis or Alzheimer's disease,' she said. 'It really is vital to humanity.' While the exact financial toll remains uncertain, university leaders say the impact is already being felt — and may only get worse. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Tips to take care of your brain for Alzheimer's and Brain Health Awareness Month
Tips to take care of your brain for Alzheimer's and Brain Health Awareness Month

Yahoo

time5 hours ago

  • Yahoo

Tips to take care of your brain for Alzheimer's and Brain Health Awareness Month

June is Alzheimer's and Brain Health Awareness Month and people hoping to spread that awareness said there are things you can do to take charge of your brain health. Brain changes that cause Alzheimer's can begin 20 years or more before symptoms appear. Work to start on Rockdale Road next week Doing things like exercising, eating right, getting good quality sleep, and controlling blood pressure can improve brain health and reduce the risk of cognitive decline. While age and family history are factors, these can naturally help you to reduce your risk. Millcreek man says over $1000 was stolen from EBT account 'It's not just the individual with the diagnosis, but it's the over 480 thousand caregivers here in the state of Pennsylvania that are providing that care. It's the family members that are in that circle of care who need that information and support. We want people to know they're not alone,' said Sara Murphy, vice president of programs and services for the Alzheimer's Association Greater PA Chapter. Early detection of cognitive diseases is crucial. The Alzheimer's Association also has a help line that anyone can call to get support at 1-800-272-3900. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Blood test for Alzheimer's could soon be available on the NHS
Blood test for Alzheimer's could soon be available on the NHS

Yahoo

time10 hours ago

  • Yahoo

Blood test for Alzheimer's could soon be available on the NHS

A new blood test for Alzheimer's disease has been found to accurately detect early symptoms of the illness, according to new research. Experts from the Mayo Clinic in the US examined two proteins in blood plasma – amyloid beta 42/40 and p-tau217 – which are associated with amyloid plaque build-up, a hallmark of Alzheimer's disease, to provide further evidence that blood tests can accurately diagnose dementia. The study, which was carried out on more than 500 people in an outpatient memory clinic, found the blood test was highly accurate, with 95 per cent sensitivity. That means it was 95 per cent accurate in picking up people with memory problems, with very few cases missed. It was also 82 per cent for specificity, meaning it was also highly accurate in ruling out people without dementia. The blood test has already been approved by the Food and Drug Administration regulator in the US. Dr Gregg Day, who led the study in the Alzheimer's and Dementia journal, said the test was as good as more invasive tests currently in use. 'When performed in the outpatient clinical setting, this is similar to the accuracy of cerebrospinal fluid biomarkers of the disease and is much more convenient and cost-effective.' Overall, researchers found that p-tau217 levels were higher in patients with Alzheimer's disease versus those without the disease. Dr Day said the next steps in the research were to evaluate blood-based testing in more diverse patient populations and people with early Alzheimer's who show no cognitive symptoms. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results 'suggest this test is very accurate' and could be used alongside other tests and observations from a trained health professional. 'While focused on Alzheimer's disease, the test was evaluated in people with other types of dementias too, showing that it may help with differentiate causes of cognitive decline – though more research in diverse groups of individuals and in community-based setting is still needed. 'Currently diagnosis options in the UK are often slow, expensive and can be invasive, meaning thousands miss out on the benefits one can bring. 'It's great to see blood tests like this approved for clinical use in the US – we hope to see the same in the NHS, which is why we're part of the Blood Biomarker Challenge.' The Blood Biomarker Challenge is a multi-million-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. Its goal is to bring blood tests for dementia diagnosis to the NHS by 2029. Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal. 'Blood tests in this study look at p-tau217 and amyloid beta 42/40, and showed the tests offered high accuracy in confirming Alzheimer's disease. 'This study adds to the growing evidence that blood tests can detect the diseases that cause dementia in people with early memory and thinking problems. 'An important point to consider is that people taking part in research don't always reflect the full diversity of those affected by dementia, who might have additional conditions or other characteristics. 'That is why work is needed to understand whether these blood tests work in a real-world setting.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store